EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Harnessing the role of transforming growth factor-β in glioblastoma: a focus on phytochemicals

Ali Nakhaei, Mehdi Abedi, Sadaf Afshari, Alireza Mohtashami, Mohammad Jalili-Nik, Mahsa Jalali, Amir R Afshari

Medical Oncology · 2025

DOI: 10.1007/s12032-025-03090-9 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Medical Oncology, 2025. Verfasst von Ali Nakhaei und 6 weiteren Autor:innen. Beteiligte Einrichtung: Student Research Committee, MMS.C., Islamic Azad University, Mashhad, Iran. Hauptthemen laut MEDLINE: Glioblastoma, Brain Neoplasms, Transforming Growth Factor beta, Phytochemicals. Die Arbeit nennt 160 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastoma (GBM), the most aggressive type of primary brain tumor in adults, is characterized by a poor prognosis and considerable resistance to current therapies. Traditional treatment approaches-surgery, radiation, and chemotherapy-offer few clinical benefits and are often linked to increased recurrence rates and significant adverse effects. This underscores the urgent need for novel therapeutic strategies. Targeting the transforming growth factor-beta (TGF-β) signaling pathway is a viable strategy. TGF-β acts as a tumor suppressor during the first stages of cancer but promotes tumor progression, angiogenesis, immune evasion, and the creation of an immunosuppressive tumor microenvironment in GBM. The deregulation of TGF-β signaling has been shown to interact with essential carcinogenic pathways, including the Wnt/β-catenin, PI3K/AKT, and Notch pathways, therefore aggravating GBM pathogenesis. TGF-β plays a pivotal role in controlling glioma stem cells and influencing the permeability of the blood-brain barrier, making it an attractive target for therapeutic intervention. Novel treatment approaches, including small-molecule inhibitors and monoclonal antibodies, as well as the use of phytochemicals such as flavonoids, quercetin, and other phytochemicals targeting specific elements of the TGF-β signaling pathway, have shown encouraging results in preclinical investigations and early-stage clinical trials. These novel strategies may enhance clinical outcomes and mitigate treatment limitations in GBM therapy by leveraging this system's combined tumor-suppressive and immune-regulatory properties.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaBrain NeoplasmsTransforming Growth Factor betaPhytochemicalsHumansSignal TransductionAnimals

Stichwörter der Autor:innen

Brain tumorCancerGlioblastomaPhytochemicalsTGF-β

Substanzen

Transforming Growth Factor betaPhytochemicals

Autor:innen und Institutionen

  • Student Research Committee, MMS.C., Islamic Azad University, Mashhad, Iran.
  • Student Research Committee, Faculty of Medicine, Mashhad Medical Sciences, Islamic Azad University, Mashhad, Iran.
  • Student Research Committee, Faculty of Dentistry, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Department of Medical Biochemistry, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Department of Basic Sciences, Faculty of Medicine, Mashhad Medical Sciences, Islamic Azad University, Mashhad, Iran.
  • Department of Basic Sciences, Faculty of Medicine, Mashhad Medical Sciences, Islamic Azad University, Mashhad, Iran. Amirreza.afshari2@gmail.com.

Zitieren

APA

Nakhaei, A., Abedi, M., Afshari, S., Mohtashami, A., Jalili-Nik, M., Jalali, M., & Afshari, A. R. (2025). Harnessing the role of transforming growth factor-β in glioblastoma: a focus on phytochemicals. Medical Oncology. https://doi.org/10.1007/s12032-025-03090-9

Vancouver

Nakhaei A, Abedi M, Afshari S, Mohtashami A, Jalili-Nik M, Jalali M, et al. Harnessing the role of transforming growth factor-β in glioblastoma: a focus on phytochemicals. Medical Oncology. 2025. doi:10.1007/s12032-025-03090-9

BibTeX
@article{Nakhaei2025,
  author = {Nakhaei, Ali and Abedi, Mehdi and Afshari, Sadaf and Mohtashami, Alireza and Jalili-Nik, Mohammad and Jalali, Mahsa and Afshari, Amir R},
  title = {Harnessing the role of transforming growth factor-β in glioblastoma: a focus on phytochemicals},
  journal = {Medical Oncology},
  year = {2025},
  doi = {10.1007/s12032-025-03090-9}
}
Kostenlos starten →